How Medicaid prescription limits affect treatment for opioid use disorder
Impact of Medicaid Prescription Cap Policies on Treatment Outcomes for Opioid Use Disorder: A National Mixed Methods Study
This study looks at how limits on Medicaid prescriptions affect people with opioid use disorder, focusing on how these rules impact access to important treatments like methadone and buprenorphine for those who are low-income.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brown University NIH-funded |
| Lab location | 1 site (Providence, United States) |
| Project ID | NIH-11019804 on NIH RePORTER |
What this research studies
This research investigates the impact of Medicaid prescription cap policies on individuals with opioid use disorder (OUD). It aims to understand how these policies, which limit the number of prescriptions that can be filled, affect access to effective treatments like methadone, buprenorphine, and naltrexone. By examining the experiences of low-income Medicaid beneficiaries, the study will gather qualitative and quantitative data to assess the implications of these caps on their health outcomes. The findings could help inform policy changes to improve access to necessary medications for those struggling with OUD.
Who could benefit from this research
Good fit: Ideal candidates for this research are low-income individuals with opioid use disorder who are enrolled in Medicaid.
Not a fit: Patients who are not enrolled in Medicaid or do not have opioid use disorder may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved access to life-saving treatments for individuals with opioid use disorder.
How similar studies have performed: While some older studies have explored Medicaid data, this research specifically focuses on opioid use disorder and is considered novel in its approach.
Where this research is happening
Providence, United States
- Brown University — Providence, United States (Active)
Researchers
- Principal investigator: Hughto, Jaclyn White — Brown University
- Study coordinator: Hughto, Jaclyn White
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.